Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 6 May 2020, 16:15 HKT/SGT
Share:
S&P Global Ratings Affirm HTSC & Huatai International's Positive Outlook

HONG KONG, May 6, 2020 - (ACN Newswire) - S&P Global Ratings today released a report affirming its positive outlook, 'BBB' long-term and 'A-2' short-term issuer credit ratings on HTSC (Stock Code: 6886:HK; "The Company") and its core subsidiary, while also affirming the Company's 'BBB' long-term issuer credit ratings. S&P Global Ratings believes the Company's risk-adjusted capital (RAC) ratio can be sustainably managed above 15% for the next one to two years, and thus reach its threshold for a potential upgrade.

"The positive outlook on HTSC reflects our view of a one-in-three chance that the strengthening capitalization could result in an upgrade over the next two years. Our view also reflects the Company's adequate first-quarter earnings amid the COVID-19 outbreak in China and controlled exposure to directional equity trading, while maintaining a buffer above our threshold for a very strong capital assessment, despite market volatility."

This affirmed rating and denoted upgrade will further cement HTSC's position within the global capital market, further reduce the cost of overseas financing, and create beneficial conditions for cross-border business. HTSC's annual revenue in 2019 was RMB 32.437billion, up 32.36% year-on-year, of which Huatai International accounted for 12.48%.



Topic: Press release summary Sectors: Daily Finance, Daily News
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
GIC Invests US$100M in Ascletis Pharma (1672. HK): Anchoring Long-Term Capital in China's Core Innovative Drug Assets  
Feb 6, 2026 17:45 HKT/SGT
GIC Private Limited initiated a stake in Ascletis Pharma (01672) by 64,128,000 shares at a price of HKD 12.18 per share  
Feb 6, 2026 17:01 HKT/SGT
COSMOPlat Introduces Full-Stack AI to Hong Kong for Trillion-Dollar Industrial Digitalization  
Feb 6, 2026 16:34 HKT/SGT
Everest Medicines Announces China NMPA Approval of VELSIPITY(R) for Adults with Moderately to Severely Active Ulcerative Colitis  
Feb 6, 2026 14:17 HKT/SGT
Spritzer Celebrates Continued Excellence with Dual Recognition at Putra Brand Awards 2025 and Superior Taste Award 2025  
Feb 6, 2026 13:13 HKT/SGT
Mitsubishi Motors Launches the All-New Versa Van in the Philippine Market  
Friday, February 6, 2026 12:34:00 PM
Eternal Beauty Holdings Limited and Lane Crawford Debut Landmark Fragrance, Further Expanding Footprint in High-Margin Niche Fragrance Market  
Feb 6, 2026 12:21 HKT/SGT
Distinct Healthcare Successfully Listed on HKEX, Bolstered by Premium Customer Base and All-Star Cornerstone Investors  
Feb 6, 2026 11:44 HKT/SGT
Establishment of the World's First*1 Global Supply Chain to Introduce the Use of Renewable Plastics in Sony's High-Performance Products  
Friday, February 6, 2026 10:50:00 AM
Eisai and Henlius Enter into Exclusive Commercial License Agreement for Anti-PD-1 Antibody Serplulimab in Japan  
Friday, February 6, 2026 10:31:00 AM
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: